Indeed, inhibiting m6A modification by 3‐deazaadenosine (DAA) treatment attenuated the regulation of ETV5 expression by YTHDF2 in the indicated HCC cells (Figure 5D). This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.